Skip to main content

JOURNALS

Fournier Gangrene in a patient receiving chemo–radiation for rectal cancer

Maria Pittaka1, Chrysanthos Georgiou2, Petros Polyviou3, Pantelis Kountourakis4, Panayiotis Loizou2, Ifigenia Constantinou4, Demetris Andreopoulos1 and Vassilios P Vassiliou1,*

1 Department of Radiation Oncology, Bank of Cyprus Oncology Center, Nicosia, Cyprus, 2 Department of General Surgery, Nicosia General Hospital, Nicosia, Cyprus, 3 Diagnostic Radiology, Bank of Cyprus Oncology Center, Nicosia, Cyprus, and 4 Department of Medical Oncology, Bank of Cyprus Oncology Center, Nicosia, Cyprus
https://academic.oup.com/omcr/article/2018/2/omx101/4911313?guestAccessKey=3e0a1696-3081-4e77-a572-b9158767d969

 

Leptomeningeal metastases originated from esophagogastric junction/gastric cancer: A brief report of two cases.
Kountourakis P, Papamichael D, Haralambous H, Michael M, Nakos G, Lazaridou S, Fotiou E, Vassiliou V, Andreopoulos D.


World J Gastrointest Oncol. 2018 Jan 15;10(1):56-61. doi: 10.4251/wjgo.v10.i1.56.


PMID: 29375749

 

Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial.

Ruff P, Van Cutsem E, Lakomy R, Prausova J, van Hazel GA, Moiseyenko VM, Soussan-Lazard K, Dochy E, Magherini E, Macarulla T, Papamichael D.

J Geriatr Oncol. 2017 Aug 12. pii: S1879-4068(17)30140-6. doi: 10.1016/j.jgo.2017.07.010. [Epub ahead of print]

 

Management of gastric cancer in older adults.

Matthaiou C, Papamichael D.

J Geriatr Oncol. 2017 Aug 1. pii: S1879-4068(17)30136-4. doi: 10.1016/j.jgo.2017.07.009. [Epub ahead of print]

 

Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P.
World J Methodol. 2017 Mar 26;7(1):9-15. doi: 10.5662/wjm.v7.i1.9. eCollection 2017 Mar 26. Review.
PMID: 28396845

 

Geriatric factors and outcomes in metastatic colorectal cancer

European Journal of Cancer, DOI: http://dx.doi.org/10.1016/j.ejca.2016.11.003

Demetris Papamichael, Matti Aapro

 

The effectiveness of thyme honey for the management of treatment-induced xerostomia in head and neck cancer patients: A feasibility randomized control trial
Andreas Charalambous, Ekaterini Lambrinou, Nicos Katodritis, Dimitrios Vomvas, Vasilios Raftopoulos, Morpho Georgiou, Lefkios Paikousis, Melanie Charalambous
European Journal of Oncology Nursing 27 (2017) 1-8

 

BRCA1 and BRCA2 mutation testing in Cyprus; a population based study.
Loizidou MA, Hadjisavvas A, Pirpa P, Spanou E, Delikurt T, Tanteles GA, Daniel M, Kountourakis P, Malas S, Ioannidis G, Zouvani I, Kakouri E, Papamichael D, Marcou Y, Anastasiadou V, Kyriacou K.
Clin Genet. 2016 Oct 13. doi: 10.1111/cge.12886. [Epub ahead of print]


 

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Dalgleish AG, Stebbing J, Adamson DJ, Arif SS, Bidoli P, Chang D, Cheeseman S, Diaz-Beveridge R, Fernandez-Martos C, Glynne-Jones R, Granetto C, Massuti B, McAdam K, McDermott R, Martín AJ, Papamichael D, Pazo-Cid R, Vieitez JM, Zaniboni A, Carroll KJ, Wagle S, Gaya A, Mudan SS.
Br J Cancer. 2016 Oct 11. doi: 10.1038/bjc.2016.342


Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).
Dervenis C, Xynos E, Sotiropoulos G, Gouvas N, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Chrysou E, Emmanouilidis C, Georgiou P, Karachaliou N, Katopodi O, Kountourakis P, Kyriazanos I, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Tekkis P, Triantopoulou C, Tzardi M, Vassiliou V, Vini L, Xynogalos S, Ziras N, Souglakos J.
Ann Gastroenterol. 2016 Oct-Dec;29(4):390-416.


Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?
Papadimitriou K, Kountourakis P, Kottorou AE, Antonacopoulou AG, Rolfo C, Peeters M, Kalofonos HP.
Mol Diagn Ther. 2016 Jul 8. [Epub ahead of print] Review.

 

Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.
Papamichael D, Renfro LA, Matthaiou C, Yothers G, Saltz L, Guthrie KA, Van Cutsem E, Schmoll HJ, Labianca R, André T, O'Connell M, Alberts SR, Haller DG, Kountourakis P, Sargent DJ; Adjuvant Colon Cancer Endpoints (ACCENT) Group.
J Geriatr Oncol. 2016 Jul 25. pii: S1879-4068(16)30088-1. doi: 10.1016/j.jgo.2016.07.002. [Epub ahead of print] PMID:27468630

 

Guided Imagery And Progressive Muscle Relaxation as a Cluster of Symptoms Management Intervention in Patients Receiving Chemotherapy: A Randomized Control Trial.

Authors
Charalambous A1,2, Giannakopoulou M3, Bozas E3, Marcou Y4, Kitsios P4, Paikousis L5.

Citation
PLoS One. 2016 Jun 24;11(6):e0156911. doi: 10.1371/journal.pone.0156911. eCollection 2016.

 

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D.
Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5.
PMID:27380959

 

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.

Bolla M, Maingon P, Carrie C, Villa S, Kitsios P, Poortmans PM, Sundar S, van der Steen-Banasik EM, Armstrong J, Bosset JF, Herrera FG, Pieters B, Slot A, Bahl A, Ben-Yosef R, Boehmer D, Scrase C, Renard L, Shash E, Coens C, van den Bergh AC, Collette L.

J Clin Oncol. 2016 May 20;34(15):1748-56. doi: 10.1200/JCO.2015.64.8055. Epub 2016 Mar 14.

 

Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.
Xynos E, Gouvas N, Triantopoulou C, Tekkis P, Vini L, Tzardi M, Boukovinas I, Androulakis N, Athanasiadis A, Christodoulou C, Chrysou E, Dervenis C, Emmanouilidis C, Georgiou P, Katopodi O, Kountourakis P, Makatsoris T, Papakostas P, Papamichael D, Pentheroudakis G, Pilpilidis I, Sgouros J, Vassiliou V, Xynogalos S, Ziras N, Karachaliou N, Zoras O, Agalianos C, Souglakos J; [the Executive Team on behalf of the Hellenic Society of Medical Oncology (HeSMO)].
Ann Gastroenterol. 2016 Jan-Mar;29(1):3-17.
PMID:26752945

 

The ALPPS procedure as a novel "liver-first" approach in treating liver metastases of colon cancer: the first experience in Greek Cypriot area.
Petrou A, Moris D, Kountourakis P, Fard-Aghaie M, Neofytou K, Felekouras E, Papalampros A.
World J Surg Oncol. 2016 Mar 8;14(1):67. doi: 10.1186/s12957-016-0827-3.

 

Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).
Xynos E, Tekkis P, Gouvas N, Vini L, Chrysou E, Tzardi M, Vassiliou V, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A,
Christodoulou C, Dervenis C, Emmanouilidis C, Georgiou P, Katopodi O, Kountourakis P, Makatsoris T, Papakostas P, Papamichael D,
Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Triantopoulou C, Xynogalos S, Karachaliou N, Ziras N, Zoras O, Souglakos J;
[the Executive Team on behalf of the Hellenic Society of Medical Oncologists (HeSMO)].
Ann Gastroenterol. 2016 Apr-Jun;29(2):103-26. doi: 10.20524/aog.2016.0003.

 

Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.
Kountourakis P, Souglakos J, Gouvas N, Androulakis N, Athanasiadis A, Boukovinas I, Christodoulou C, Chrysou E, Dervenis C, Emmanouilidis C, Georgiou P, Karachaliou N, Katopodi O, Makatsoris T, Papakostas P, Pentheroudakis G, Pilpilidis I, Sgouros J, Tekkis P, Triantopoulou C, Tzardi M, Vassiliou V, Vini L, Xynogalos S, Xynos E, Ziras N, Papamichael D.
Ann Gastroenterol. 2016 Jan-Mar;29(1):18-23.PMID:26751386 Free PMC Article

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
Thierry André, Armand de Gramont, Dewi Vernerey, Benoist Chibaudel, Franck Bonnetain, Annemilaï Tijeras-Raballand, Aurelie Scriva, Tamas Hickish, Josep Tabernero, Jean Luc Van Laethem, Maria Banzi, Eduard Maartense, Einat Shmueli, Goran U. Carlsson, Werner Scheithauer, Demetris Papamichael, Marcus Möehler, Stefania Landolfi, Pieter Demetter, Soudhir Colote, Christophe Tournigand, Christophe Louvet, Alex Duval, Jean-François Fléjou and Aimery de Gramont
Journal of Clinical Oncology, JCO published online on November 2, 2015; DOI:10.1200/JCO.2015.63.4238

Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG).
Biganzoli L, Lichtman S, Michel JP, Papamichael D, Quoix E, Walko C, Aapro M.
Eur J Cancer. 2015 Sep 1. pii: S0959-8049(15)00780-7. doi: 10.1016/j.ejca.2015.08.005. [Epub ahead of print] Review.

 Difficulties in deciding whether to ablate patients with putatively "low-intermediate-risk" differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study.
Frangos S
, Iakovou IP, Marlowe RJ, Eftychiou N, Patsali L, Vanezi A, Savva A, Mpalaris V, Giannoula EI.
Eur J Nucl Med Mol Imaging. 2015 Aug 1. [Epub ahead of print]

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
Pentheroudakis G, Kotoula V, Fountzilas E, Kouvatseas G, Basdanis G, Xanthakis I, Makatsoris T, Charalambous E, Papamichael D, Samantas E, Papakostas P, Bafaloukos D, Razis E, Christodoulou C, Varthalitis I, Pavlidis N, Fountzilas G. BMC Cancer. 2014 Feb 20;14:111. doi: 10.1186/1471-2407-14-111

The mutational spectrum of Lynch syndrome in cyprus.
Loizidou MA, Neophytou I, Papamichael D, Kountourakis P, Vassiliou V, Marcou Y, Kakouri E, Ioannidis G, Philippou C, Spanou E, Tanteles GA, Anastasiadou V, Hadjisavvas A, Kyriacou K.
PLoS One. 2014 Aug 18;9(8):e105501. doi: 10.1371/journal.pone.0105501. eCollection 2014. PMID: 25133505

 

Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward.
Papadimitriou K, Antoniou G, Rolfo C, Russo A, Bronte G, Vassiliou V, Papamichael D, Peeters M, Kountourakis P.
Gastroenterol Res Pract. 2015;2015:650846. doi: 10.1155/2015/650846. Epub 2015 May 26. Review. PMID: 26101524

  Melanoma of the gallbladder: appropriate surgical management and review of the literature.
Demetris Christou, Nicos Katodritis, Marios P. Decatris, Angela Katodritou, Ioannis Michaelides, Nicolaos Nicolaou, Michalis Kounoushis and Panayiotis Hadjicostas
Clinical Case Reports 2014;2(4)

 Voice disorders induced by bevacizumab administration in an ovarian cancer patient: An underestimated and rare toxicity.

Kountourakis P, Antoniou G, Papadimitriou K, Vassiliou V, Syrigos D, Philippou M, Papamichael D.

Hematol Oncol Stem Cell Ther. 2014 Jul 25. pii: S1658-3876(14)00050-8. doi: 10.1016/j.hemonc.2014.06.003. [Epub ahead of print]

Treatment of colorectal cancer in older patients. International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.

Papamichael D, Audisio RA, Glimelius B, de Gramont A, Glynne-Jones R, Haller D, Köhne CH, Rostoft S, Lemmens V, Mitry E, Rutten H, Sargent D, Sastre J, Seymour M, Starling N, Van Cutsem E, Aapro M.

Ann Oncol. 2014 Jul 11. pii: mdu253. [Epub ahead of print]

 FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study.

Geva R, Vecchione L, Kalogeras KT, Vittrup Jensen B, Lenz HJ, Yoshino T, Paez D, Montagut C, Souglakos J, Cappuzzo F, Cervantes A, Frattini M, Fountzilas G, Johansen JS, Høgdall EV, Zhang W, Yang D, Yamazaki K, Nishina T, Papamichael D, Vincenzi B, Macarulla T, Loupakis F, De Schutter J, Spindler KL, Pfeiffer P, Ciardiello F, Piessevaux H, Tejpar S.

Gut. 2014 Jul 10. pii: gutjnl-2014-307234. doi: 10.1136/gutjnl-2014-307234. [Epub ahead of print]

 Treatment of older patients with colorectal cancer: a perspective review.

Kordatou Z, Kountourakis P, Papamichael D.

Ther Adv Med Oncol. 2014 May;6(3):128-40. doi: 10.1177/1758834014523328. Review.

 EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.

Razis E, Pentheroudakis G, Rigakos G, Bobos M, Kouvatseas G, Tzaida O, Makatsoris T, Papakostas P, Bai M, Goussia A, Samantas E, Papamichael D, Romanidou O, Efstratiou I, Tsolaki E, Psyrri A, De Roock W, Bafaloukos D, Klouvas G, Tejpar S, Kalogeras KT, Pectasides D, Fountzilas G.

J Cancer Res Clin Oncol. 2014 May;140(5):737-48. doi: 10.1007/s00432-014-1626-2. Epub 2014 Mar 5.

 

 

Adjuvant therapy for resectable pancreatic adenocarcinoma: Review of the current treatment approaches and future directions.
Antoniou G, Kountourakis P, Papadimitriou K, Vassiliou V, Papamichael D.
Cancer Treat Rev. 2014 Feb;40(1):78-85. doi: 10.1016/j.ctrv.2013.05.008. Epub 2013 Jun 26.

The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.
Strimpakos A, Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Andreadou A, Sgouros J, Zizi-Sermpetzoglou A, Kominea A, Televantou D, Razis E, Galani E, Pectasides D, Tejpar S, Syrigos K, Fountzilas G.
Clin Colorectal Cancer. 2013 Dec;12(4):267-274.e2. doi: 10.1016/j.clcc.2013.07.001. Epub 2013 Sep 17.

Radiotherapy capacity in Europe
Charalambous H, Marcou Y, Katodritis N, Kountourakis P, Andreopoulos D.

Lancet Oncol. 2013 May;14(6):e196

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Xanthakis I, Sgouros J, Televantou D, Kafiri G, Tsamandas AC, Razis E, Galani E, Bafaloukos D, Efstratiou I, Bompolaki I, Pectasides D, Pavlidis N, Tejpar S, Fountzilas G.
BMC Cancer. 2013 Feb 2;13(1):49. [Epub ahead of print]

Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients.
Krikelis D, Bobos M, Karayannopoulou G, Resiga L, Chrysafi S, Samantas E, Andreopoulos D, Vasiliou V, Ciuleanu E, Fountzilas G.
BMC Clin Pathol. 2013 Jan 29;13:1

The role of radiotherapy (RT) in the management of metastatic bone disease
Vassiliou V, Kountourakis P, Kardamakis D
(FCO 2012;3:35-40)


The role of radiotherapy (RT) for the management of painful bone metastases.
Vassiliou V, Vomvas D, Kountourakis P, Polyviou P, Andreopoulos D
(Journal of Pain Management 2012;5:4)


Pharmacologic management of uncomplicated painful bone metastases
Vomvas D, Kountourakis P, Polyviou P, Andreopoulos D, Vassiliou V

(Journal of Pain Management 2012;5:4)

Low-grade cribriform cystadenocarcinoma of the parotid gland
Dimitrios Vomvas, Stavros Kallis, Petros Polyviou, Haris Charalambous, Nicos Katodritis
Forum of Clinical Oncology, Vol 3, No 4 (2012)

Treatment of colorectal cancer in older patients.
Audisio RA, Papamichael D.
Nat Rev Gastroenterol Hepatol. 2012 Dec;9(12):716-25. doi: 10.1038/nrgastro.2012.196. Epub 2012 Oct 9
 
Adjuvant chemoradiotherapy (CRT) for high-risk gastric cancer (GC) patients: single-center experience using infusional 5-fluorouracil (5FU) and radiotherapy (RT).
Papadimitriou K, Vassiliou V, Kountourakis P, Polyviou P, Andreopoulos D, Papamichael D.
Med Oncol. 2012 Dec;29(4):2716-7. doi: 10.1007/s12032-012-0206-z. Epub 2012 Mar 15.
 
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A.
Ann Oncol. 2012 Oct;23(10):2479-516.

Chemo re-irradiation in recurrent head and neck cancer: a single institution experience.
N. Katodritis, H. Charalampous, D. Vomvas.
J BUON Vol. 17, No 2, 2012, pp 397

Assessment of sexual function in patients with cancer undergoing radiotherapy - a single centre prospective study.
Vomvas D
, Iconomou G, Soubasi E, Leotsinidis M, Kalofonos HP, Beratis S, Kardamakis D, Assimakopoulos K.
Anticancer Res. 2012 Feb;32(2):657-64.

Mesothelioma in Cyprus: a case series (1997-2007).
Orphanos G, Charalambous C, Vrezas I, Kales SN, Haralambous H, Katodritis N, Christodoulides G, Maimaris M, Soteriades ES.
Hematol Oncol Stem Cell Ther. 2011;4(4):193-4. PMID: 22198194 [PubMed - in process]

Abolished circadian rhythm of salivary cortisol in elite artistic gymnasts
Neoklis A. Georgopoulos, Loredana Rottstein, Athanasios Tsekouras, Anastasia heodoropoulou, Eftychia Koukkou, Panagiotis Mylonas, George Polykarpou, Evgenia Lampropoulou, Gregoris Iconomou, Michel Leglise, Apostolos G. Vagenakis, Kostas B. Markou
Steroids Volume 76, Issue 4, March 2011, Pages 353–357

Targeted agents: review of toxicity in the elderly metastatic colorectal cancer patients.
Papamichael D, Kyriakou F, Kountourakis P

Target Oncol. 2011 Nov 9. [Epub ahead of print]

Barrett’s esophagus: treatment or observation of a major precursor factor of esophageal cancer?
P. Kountourakis,
K. Papademetriou, A. Ardavanis, D. Papamichael
J BUON 16: 425-430, 2011

Isolated right atrial metastasis of malignant melanoma mimicking a myxoma.
Kontozis L, Soteriou M, Papamichael D, Economides C, Bagdades E, Christou C, Oxynou C.
Hellenic J Cardiol. 2011 May-Jun;52(3):281-4

Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities.
Vassiliou Vassilios, Andreopoulos Dimitrios, Frangos Savvas,
Tselis Nicolaos, Giannopoulou Efstathia, Lutz Stephen.
Clinical Oncology Journal. Accepted for publication

Visual and hearing loss due to colorectal meningeal carcinomatosis: a case-based review
Kountourakis P
, Ardavanis A.
Clin Adv Hematol Oncol. 2010 Aug;8(8):567-8. Review. No abstract available. PMID: 20966894 [PubMed - indexed for MEDLINE]Related citations

Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience
Kountourakis P,
Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA.
Cancer. 2010 Oct 19. [Epub ahead of print]PMID: 20960497 [PubMed - as supplied by publisher]Related citations

A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
Iliopoulou EG, Kountourakis P, Karamouzis MV, Doufexis D, Ardavanis A, Baxevanis CN, Rigatos G, Papamichail M, Perez SA.
Cancer Immunol Immunother. 2010 Dec;59(12):1781-9. Epub 2010 Aug 12.PMID: 20703455 [PubMed - indexed for MEDLINE]Related citations

Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer
Kountourakis P
, Doufexis D, Maliou S, Karagiannis A, Kardara E, Margari C, Sykoutri D, Tzovaras A, Ardavanis A.
Anticancer Res. 2010 Jul;30(7):2969-71.PMID: 20683040 [PubMed - indexed for MEDLINE]

Why are older patients excluded from clinical trials?
Evaggelos Voulgaris, Dimitrios Vomvas, Georgios Kesisis, Athanasios Karampeazis, Athanasios Pallis
Forum of Clinical Oncology;1(3):42-46

Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer
Eliza Hawkes, Alicia F.C. Okines, Demetris Papamichael, Sheela Rao, Sue Ashley, Haris Charalambous, Alona Koukouma, Ian Chau, David Cunningham
European Journal of Cancer, 2010, [Epub ahead of print]

Neoadjuvant  therapy for locally advanced breast cancer: focus on chemotherapy and biological targeted treatments’ armamentarium
K.Papademetriou,
  A.Ardavanis,  P.Kountourakis
(J Thorac Dis 2010; 3:160-170)

Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.
Kalofonos HP, Papakostas P, Makatsoris T, Papamichael D, Vourli G, Xanthakis I, Aravantinos G, Papadimitriou C, Pentheroudakis G, Varthalitis I, Samelis G, Syrigos KN, Xiros N, Stavropoulos M, Kosmidis P, Christodoulou C, Linardou H, Skondra M, Pectasides D, Economopoulos T, Fountzilas G.
Anticancer Res. 2010 Oct;30(10):4325-33.

Intramedullary Spinal Cord Metastasis in a Patient with Colon Cancer: A Case Report.
Vassiliou V, Papamichael D, Polyviou P, Koukouma A, Andreopoulos D.
J Gastrointest Cancer. 2010 Sep 14. [Epub ahead of print]PMID: 20838936 [PubMed - as supplied by publisher]

Effects of KRAS, BRAF, NRAS and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective population-based Consortium analysis.
De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G, Kalogeras KT, Kotoula V, Papamichael D, Laurent-Puig P, Penault-Llorca F, Rougier P, Vincenzi B, Santini D, Tonini G, Cappuzzo F, Frattini M, Molinari F, Saletti P, De Dosso S, Martini M, Bardelli A, Siena S, Sartore-Bianchi A, Tabernero J, Macarulla T, Di Fiore F, Gangloff AO, Ciardiello F, Pfeiffer P, Qvortrup C, Hansen TP, Van Cutsem E, Piessevaux H, Lambrechts D, Delorenzi M, Tejpar S. 
Lancet Oncol. 2010 Jul 7. [Epub ahead of print]

Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial.
Ocvirk J, Brodowicz T, Wrba F, Ciuleanu TE, Kurteva G, Beslija S, Koza I, Pápai Z, Messinger D, Yilmaz U, Faluhelyi Z, Yalcin S, Papamichael D, Wenczl M, Mrsic-Krmpotic Z, Shacham-Shmueli E, Vrbanec D, Esser R, Scheithauer W, Zielinski CC. 
World J Gastroenterol. 2010 Jul 7;16(25):3133-43

Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria.
Vassiliou V, Andreopoulos D
.
Br J Cancer. 2010 Jul 27. PMID: 20664592

Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: feasibility and reproducibility in a multi-institutional Hellenic collaborative study.
Lasithiotakis K, Economou G, Gogas H, Ioannou C, Perisynakis K, Filis D, Kastana O, Bafaloukos D, Decatris M, Catodritis N, Frangia K, Papadakis G, Magarakis M, Tsoutsos D, Chrysos E, Chalkiadakis G, Zoras O.
Oncol Rep. 2010 Apr;23(4):1077-83.
PMID: 20204294 [PubMed - indexed for MEDLINE

Osteonecrosis of the jaws: Clinico-pathlogical and radiologic characteristics, prevalence and treatment strategies.
Vassiliou V
, Tselis N, Kardamakis D.
Strahlenther Onkol. 2010 Jul;186(7):367-73. Epub 2010 Apr 26. Review.

EORTC Elderly Task Force experts’ opinion for the treatment of colon cancer in older patients.
A.G. Pallis , D. Papamichael , R. Audisio , M. Peeters , G. Folprecht , D. Lacombe , E. Van Cutsem.
Cancer Treat Rev. 2010 Feb;36(1):83-90

Implications of k-ras mutation status for the treatment of metastatic colorectal cancer.
Fortunato Ciardiello, Sabine Tejpar, Demetris Papamichael. 
Target Oncol. 2009 Dec;4(4):311-22

Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
Kountourakis P
, Psyrri A, Scorilas A, Markakis S, Kowalski D, Camp RL, Diamandis EP, Dimopoulos MA.
Thromb Haemost. 2009 Mar;101(3):541-6.

The potential role of Bcl-2 and Ki67 expression and apoptosis in gastric carcinoma. A clinicopatholoic study.
Tsamandas AC, Kardamakis D, Tsiamalos P, Liava A, Tzelepi V, Vassiliou V, Petsas T,. Scopa CD, Vagenas K.
Anticancer Research, 2009;29:703-709

Management of symptomatic bone metastases from breast cancer with concomitant use of external radiotherapy and ibandronate: results of a prospective, pilot study.
Vassiliou V
, Kalogeropoulou C, Leotsinidis M, Tsamandas A, Petsas T, Giannopoulou E, Kardamakis D.
The Breast Journal, 2009(1):92-94

The management of metastatic bone disease with the combination of bisphosphonates and radiotherapy: From theory to clinical practice.
Vassiliou Vassilios, Kardamakis Dimitrios.
Anticancer Agents in Medicinal Chemistry, 2009;9(3):326-335.


The role of postoperative radiotherapy in patients with thymic tumors – a retrospective study and review of the literature
Vassiliou Vassilios, Tsamandas Athanassios, Katodritis Nicos, Charoulis Nikolaos, Koukouma Alona, Andreopoulos Dimitrios, Salakou Stavroula,   Zolota Vassiliki, Papathanassopoulos Panagiotis, Christodoulides Gregoris,Dougenis Dimitrios, Kardamakis Dimitrios.
Journal In VIVO, 2009;23:843-852

Concurrent application of bisphosphonates and external beam radiotherapy in patients with metastatic bone disease from renal cancer.
Vassiliou Vassilios
, Leotsinides Michael, Kalogeropoulou Christina,Kardamakis Dimitrios.
British Journal of Urology International 2009;104:417-418

Combining systemic Bisphosphonates with palliative external beam radiotherapy or bone targeted Radionuclide therapy: interactions and effectiveness.
Vassiliou V, Bruland O, Janjan N, Lutz S, Kardamakis D, Hoskin P.
Clinical Oncology, 2009;21:665-667

Kardamakis D, Vassiliou V, Chow E, eds. 
Book title: “Bone Metastases: A Translational and Clinical Approach”. Springer, 2009, ISBN: 978-1-4020-9818-5.

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991.

Randomized controlled trial
Matzinger O1, Duclos F, van den Bergh A, Carrie C, Villà S, Kitsios P, Poortmans P, Sundar S, van der Steen-Banasik EM, Gulyban A, Collette L, Bolla M; EORTC Radiation Oncology Group.

Citation
Eur J Cancer. 2009 Nov;45(16):2825-34. doi: 10.1016/j.ejca.2009.07.009. Epub 2009 Aug 12

EORTC Elderly Task Force experts' opinion for the treatment of colon cancer in older patients.
Pallis AG, Papamichael D, Audisio R, Peeters M, Folprecht G, Lacombe D, Van Cutsem E.
Cancer Treat Rev. 2009 Nov 25.

Implications of KRAS mutation status for the treatment of metastatic colorectal cancer.
Ciardiello F, Tejpar S, Papamichael D.
Target Oncol. 2009 Nov 14.

Treatment of the elderly colorectal cancer patient: SIOG expert recommendations.
D. Papamichael;
R. Audisio; J.-C. Horiot; B. Glimelius; J. Sastre; E. Mitry; E. Van Cutsem; M. Gosney; C.-H. Kohne; M. Aapro 
Ann Oncol 2009;20(1):5-16

Concomitant gastric adenocarcinoma and stromal tumor in a woman with polymyalgia rheumatica.
Kountourakis P
, Arnogiannaki N, Stavrinides I, Apostolikas N, Rigatos G.
World J Gastroenterol. 2008 Nov 21;14(43):6750-2.

Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
Kountourakis P
, Psyrri A, Scorilas A, Camp R, Markakis S, Kowalski D, Diamandis EP, Dimopoulos MA.
Cancer Sci. 2008 Nov;99(11):2224-9.

Intestinal metastases from cervical carcinoma may be falsely attributed to radiation enteropathy.
V. Vassiliou,
M. Pomoni, D. Kardamakis.
European Journal of Obstetrics, Gynecology and Reproductive Biology, 2008;137:118-127

Metastatic adenocarcinoma of parotid gland originating from the ampulla of Vater. Case report and review of the literature.
D Spyropoulou, V Vassiliou, V Tzelepi, M Kardari, AC Tsamandas, D Kardamakis.
International Journal of gastrointestinal Cancer, 2008;38:95-98.

Types of bone metastases in women with breast cancer undergoing systemic treatments.
V Vassiliou, D Kardamakis.
Medical Radiology Journal (Radiol Med) 2008;113(5):771-773

A case of osteonecrosis of the jaw in patient receiving chronic ibandronate treatment.
D Vomvas, V Vassiliou, D Kardamakis.
Journal BUON, 2008;13:441-442.

Clinical and radiologic response in patients with bone metastases managed with combined radiotherapy and bisphosphonates.
Vassiliou V, Kalogeropoulou C, Kardamakis D.
Journal of Surgical Oncology. 2008;98:567-568.

Challenges in treating older cancer patients: colon cancer.
D. Papamichael.

Ann Oncol 2008; 19 (suppl 7): vii104-vii108

Potential value of PTEN in predicting cetuximab response in colorectal cancer. An exploratory study.
Evangelia Razis, Evangelos Briasoulis,  Eleni Vrettou,  Dimosthenis V Skarlos,  Dimitrios Papamichael,  Ioannis Kostopoulos, Epaminontas Samantas, Ioannis Xanthakis, Mattheos Bobos, Eleni Galanidi, Maria Bai, Ioanna Gikonti, Alona Koukouma, Georgia Kafiri, Pavlos Papakostas, Konstantine T Kalogeras, Paris Kosmidis and George Fountzilas .
BMC Cancer 2008;  8:234

HLA Class II Alleles and the Presence of Circulating Epstein-Barr Virus DNA in Greek Patients with Nasopharyngeal Carcinoma.
Epaminondas Samantas, Angelos Nicolaou, Lemonia Skoura, Nicolaos Tselis, Nikolaos Zamboglou, George Fountzilas.Charisios Karanikiotis, Michail Daniilidis, Nikolaos Kariotis, Charalambos Bakogiannis, Theophanis Economopoulos, Samuel Murray, Demetris Papamichael.
Strahlenther Onkol. 2008;184:325–31

Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative
Pectasides D, Papaxoinis G, Pectasides E, Galani H, Razi E, Katodrytis N, et al.
Oncology Group. Oncology. 2007;72:211–8. [PubMed]

Colon Cancer Adjuvant Therapy: Current Status.  CME Journal Gastroenterology.
Papamichael D. 

Hepatology & Nutrition 2007 8(1): 3-10

Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal cancer.
Kalogera-Fountzila Anna, Karanicolas Demetrios, Katodritis Nikos, Samantas Epaminondas, Sarafopoulos Apostolos, Ikonomou Ippoliti, Zamboglou Nikolaos, Tselis Nikolaos, Dimitriadis Athanasios-Sokratis, Fountzilas George.
Strahlenther Onkol. 2006 Aug; 182(8): 458-466

Novel germline mutations in the APC gene of Cypriot patients with familial and sporadic adenomatous polyposis.
Hadjisavvas A, Papasavva D, Loizidou M, Malas S, Potamitis G, Christodoulou C, Pavlidis G, Papamichael D
Klonis C, Nasioulas G, Anastasiadou V, Kyriakou K.
Clin Genet 2006 May;69(5):404-9

Reply to ‘Lack of response of cetuximab plus oxaliplatin…’ by B. Vincenzi et al. Angela J Darby, Demetris Papamichael
Ann Oncol 28 November 2005

Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience.
Decatris M,
Sundar S, Sundar S, O'Byrne KJ
Clin Oncol (R Coll Radiol) 2005 Jun; 17(4): 249-257

Complementary role of helical CT cholangiography to MR cholangiography in the
evaluation of biliary function and kinetics.

Eracleous E, Genagritis M, Papanikolaou N, Kontou A, Prassopoullos P,
Chrysikopoulos H, Allan P, Gourtsoyiannis N
Eur Radiol. 2005 Jun 8; 1: [Epub ahead of print]

Induction Chemotherapy with Cisplatin, Epirubicin, and Paclitaxel (CEP),
Followed by Concomitant Radiotherapy and Weekly Paclitaxel for the Management of Locally Advanced Nasopharyngeal Carcinoma.
A Hellenic Cooperative Oncology Group Phase II Study.

Fountzilas G, Tolis C, Kalogera-Fountzila A, Karanikiotis C, Bai M,
Misailidou D, Samantas E, Athanassiou E, Papamichael D, Tsekeris P, Katodritis N, Nicolaou A, Plataniotis G, Makatsoris T, Papakostas P, Zamboglou N, Daniilidis J
Strahlenther Onkol. 2005 Apr; 181(4): 223-230

Endothelin-1 is a novel prognostic factor in non-small cell lung cancer.
Arun C, Decatris M, Hemingway DM, London NJ, O'Byrne KJ
Int J Biol Markers. 2004 Oct-Dec; 19(4): 262-267

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in
epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy.

Sundar S, Symonds RP, Decatris M, Kumar DM, Osman A, Vasanthan S, O'byrne KJ
Gynecol Oncol. 2004 Aug; 94(2): 502-508

Lack of pharmacokinetic interaction between 5-fluorouracil and oxaliplatin.
Joel SP, Papamichael D, Richards F, Davis T, Aslanis V, Chatelut E, Locke K,
Slevin ML, Seymour MT
Clin Pharmacol Ther. 2004 Jul; 76(1): 45-54

Description of the first two seemingly unrelated Greek Cypriot families with a
common C618R RET proto-oncogene mutation.

Neocleous V, Passalaris T, Spanou E, Kitsios P, Skordis N, Deltas CC.
Genet Test. 2004 Summer; 8(2): 163-168

Management of endocrine resistant breast cancer.
Sundar S, Decatris M, O'Byrne KJ
J Br Menopause Soc. 2004 Mar; 10(1): 16-23

Platinum-based chemotherapy in metastatic breast cancer: current status.
Decatris M,
Sundar S, O'Byrne KJ
Cancer Treat Rev. 2004 Feb; 30(1): 53-81

Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer.
Bamias A, Papamichael D, Syrigos K, Pavlidis N.
J Chemother. 2003 Jun; 15(3): 275-81

Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
Bjorkholm M, Johansson E, Papamichael D, Celsing F, Matthews J, Lister TA, Rohatiner AZ.
Semin Oncol. 2003 Apr; 30(2): 226-30

Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM, Hardan I, Raz H, Adamou A, Inbar M, Gottfried M, Merrick Y, Cohen Y, Sulkes A, Ben-Baruch N, Pfeffer RP, Brenner HJ, Rizel S.
Bone Marrow Transplant. 2003 Apr; 31(8): 655-61.

BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
Hadjisavvas A, Charalambous E, Adamou A, Christodoulou CG, Kyriacou K.
Hum Mutat 2003 Feb; 21(2): 171

Epidural metastasis in nasopharyngeal carcinoma.
Bagatzounis A ,
Erakleous E, Michaelides I.
Strahlenther Onkol 2003 Feb; 179(2): 123-8

Combined percutaneous and intraluminal radiotherapy for irresectable Klatskin tumors.
Schleicher UM, Staatz G, Alzen G, Andreopoulos D
Strahlenther Onkol, Vol 178, No 12 (2002): 682-687

Correlation between morphology, immunohistochemistry and molecular pathology in hereditary and sporadic breast cancer cases.
Hadjisavvas A, Mikellidou C, Zenios A, Zouvani I, Adamou A, Christodoulou Ch, Kyriacou K
Ultrastruct Pathol. 2002 Jul-Aug; 26(4): 237-44

Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer. Andreopoulou E, Andreopoulos D, Adamidis K, Fountzila-Kalogera A, Fountzilas G, Dimopoulos MA, Aravantinos G, Zamboglou N, Baltas D, Pavlidis N
Anticancer Res 2002 May-Jun; 22 (3): 1903-8

Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Cypriot family.
Hadjisavvas A, Adamou A, O'Dowd Phanis C, Todd CM, Kitsios P, Kyriacou K, Christodoulou CG
Oncol Rep 2002 Mar-Apr; 9(2): 383-6

Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study.
Fountzilas G, Tsavdaridis D, Kalogera-Fountzila A, Christodoulou CH, Timotheadou E, Kalofonos CH, Kosmidis P,
Adamou A,
Papakostas P, Gogas H, Stathopoulos G, Razis E, Bafaloukos D, Skarlos D
Ann Oncol 2001 Nov; 12(11): 1545-51

Prognostic role of angiogenesis in colorectal cancer.
Papamichael D

Anticancer Res. 2001 Nov-Dec; 21(6B): 4349-53

BRCA1 germline mutations in Cypriot breast cancer patients from 26 families with family history.
Hadjisavvas A, Neuhausen SL, Hoffman MD, Adamou A, Newbold RF, Kyriacou KC, Christodoulou CG
Anticancer Res. 2001 Sep-Oct; 21(5): 3307-11

Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma.
Stemmer SM, Pfeffer MR, Rizel S, Hardan I, Goffman J, Gezin A, Neumann A, Kitsios P, Alezra D, Brenner HJ
Cancer 2001 Jun 1; 91(11): 1983-91

Long-term effects on the intelligence of children treated for acute lymphoblastic leukemia.
Kolotas C, Daniel M, Demetriou L, Martin T, Kurek R, Tonus C, Gobel U, Schnabel T, Zamboglou N
Cancer Invest 2001; 19(6): 581-7

Palliative radiotherapy in recurrent head-and-neck tumors by a percutaneous superfractionated treatment schedule.
Schleicher UM, Andreopoulos D, Ammon J
Int J Radiat Oncol Biol Phys 2001 May 1; 50(1): 65-8

Intraoperative radiotherapy for pre-irradiated head and neck cancer.
Schleicher UM, Phonias C, Spaeth J, Schlondorff G, Ammon J, Andreopoulos D
Radiother Oncol 2001 Jan; 58(1): 77-81

A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma.
Mulatero CW, Penson RT, Papamichael D, Gower NH, Evans M, Rudd RM
Lung Cancer 2001 Jan; 31(1): 67-72

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A
J Clin Oncol 2000 Aug; 18(16): 2938-47

Immunohistochemical versus molecular detection of RAK antigens in breast cancer.
Kyriacou KC, Iacovou F, Adamou A, Hadjisavvas A, Rakowicz-Szulczynska EM
Exp Mol Pathol 2000 Aug; 69(1): 27-36

A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes.
Skordis N, Patsalis PC, Hettinger JA, Kontou M, Herakleous E, Krishnamani MR, Phillips JA 3rd
Horm Res 2000; 53(5): 239-45

The postoperative adjuvant radiation therapy and radiochemotherapy for UICC stage II and III rectal cancer. A retrospective analysis.
Bagatzounis A ,
Willner J, Oppitz U, Flentje M
Strahlenther Onkol 2000 Mar; 176(3): 112-7

Improved detection of breast cancer nuclei using modular neural networks.
Schnorrenberg F, Tsapatsoulis N, Pattichis CS, Schizas CN, Kollias S, Vassiliou M, Adamou A, Kyriacou K
IEEE Eng Med Biol Mag 2000 Jan-Feb; 19(1): 48-63

The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
Papamichael D

Stem Cells 2000; 18(3): 166-75

The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
Papamichael D
Oncologist 1999; 4(6): 478-87

Radioprotection of human endothelial cells with amifostine.
Andreopoulos D , Schleicher UM, Cotarelo CL, Hand S, Ammon J
Strahlenther Onkol 1999 Nov;175 Suppl 4:34 -6

Epirubicin, cisplatin and oral UFT with leucovorin ('ECU'): a phase I-II study in patients with advanced upper gastrointestinal tract cancer.
Seymour MT, Dent JT, Papamichael D, Wilson G, Cresswell H, Slevin ML
Ann Oncol 1999 Nov; 10(11):1329-33

Radioprotection of human endothelial cells by sodium selenite.
Schleicher UM, Lopez Cotarelo C, Andreopoulos D, Handt S, Ammon J
Med Klin 1999 Oct 15; 94 Suppl 3:35-8

Immunocytoma: a retrospective analysis from St Bartholomew's Hospital-1972 to 1996.
Papamichael D , Norton AJ, Foran JM, Mulatero C, Mathews J, Amess JA, Bradburn M, Lister TA, Rohatiner AZ
J Clin Oncol 1999 Sep; 17(9):2847-53

Conventionally fractionated radiotherapy of glioblastoma multiforme. Results and analysis of possible influencing factors.
Schleicher UM, Andreopoulos D, Ammon J, Gilsbach J
Front Radiat Ther Oncol 1999; 33:166-73

Combined treatment of localized prostate cancer with HDR-Iridium 192 remote brachytherapy and external beam irradiation.
Andreopoulos D , Piatkowiak M, Krenkel B, Schleicher UM, Wolff JM
Strahlenther Onkol 1999 Aug;175(8):387-91

A new method for the placement of brachytherapy probes in paranasal sinus and nasopharynx neoplasms.
Kremer B, Klimek L, Andreopoulos D, Mosges R
Int J Radiat Oncol Biol Phys 1999 Mar 15;43(5):995-1000